第一军医大学临床医学本科，南方医科大学免疫学硕士，南方医科大学附属南方医院肝病中心博士，美国佐治亚医学院（现改名为奥古斯塔大学）癌症中心博士后。

中国优生科学协会妇儿免疫学分会委员、广东省免疫学会会员、亚太免疫学会基础免疫学分会委员、中国生物医学工程学会会员、美国华人抗体协会会员；Technology in cancer research & treatment杂志副主编；广东“高校科技成果转化专家库”入库专家；广东省自然科学基金入库专家。

癌症的免疫治疗

1.通过免疫学、分子生物学及合成生物学方法设计、构建新型免疫细胞如CAR-T、CAR-NK、TCR-T治疗肿瘤；

2.设计构建新型免疫分子如抗体-药物偶联物、抗体-细胞因子融合蛋白、嵌合蛋白等治疗肿瘤。

1.Leidy D. Caraballo Galva^#, Xiaotao Jiang^#, Mohamed S. Hussein^#, Huajun Zhang, Rui Mao, Pierce Brody, Yibing Peng, Aiwu Ruth He, Mercy Kehinde-Ige, Ramses Sadek, Xiangguo Qiu, Huidong Shi, Yukai He*. Novel low-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC. Hepatology (2021). doi: 10.1002/hep.32279（中科院胃肠肝病学小类1区，TOP期刊，IF: 17.425）

2.Yixin Liu, Xinsheng Zhou, Xuan Liu, Xiaotao Jiang*. The immunology and immunotherapy for COVID-19. Expert Reviews in Molecular Medicine (2021). doi: 10.1017/erm.2021.30（中科院医学研究与实验小类3区，IF: 5.6）

3.Zhuoyan Liu, Xuan Liu, Jiaxin Liang, Yixin Liu, Xiaorui Hou, Meichuan Zhang, Yongyin Li, Xiaotao Jiang*. Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects. Frontiers in Immunology (2021). doi: 10.3389/fimmu.2021.765101（中科院免疫学小类2区，TOP期刊，IF: 7.561）

4.Chengcong Chen^#, Xiaotao Jiang^#, Xuan Liu^#, Ling Guo, Weibin Wang, Shuqin Gu, Chunhua Wen, Xuan Yi, Libo Tang, Yongyin Li*. Identification of the association between HBcAg‐specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay. Journal of Leukocyte Biology (2020). doi: 10.1002/JLB.5MA0620-023RR（中科院免疫学小类3区，IF: 4.962）

5.Xuan Liu#, Jianyun Wen#, Honglei Yi#, Xiaorui Hou, Yue Yin, Guofu Ye, Xuedong Wu*, Xiaotao Jiang*. Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release. Therapeutic advances in medical oncology (2020) doi: 10.1177/1758835920910347（中科院肿瘤学小类2区，IF: 8.168）

6.Jiang XT^#, Xu Y, Liu MF ^#, Xin H, Wang ZM, Huang, L A. Mellor, Wang W*, Wu S *. Adoptive CD8+ T cell therapy against cancer：Challenges and opportunities. Cancer Letters (2019). doi: 10.1016/j.canlet.2019.07.017.(中科院肿瘤学小类2区，IF: 8.679)

7.Wei Zhu, Yibing Peng, Lan Wang, Yuan Hong, Xiaotao Jiang, Qi Li, Heping Liu, Lei Huang, Juan Wu, Esteban Celis, Todd Merchen, Edward Kruse, Yukai He. Identification of α‐fetoprotein‐specific T‐cell receptors for hepatocellular carcinoma immunotherapy. Hepatology (2018). doi: 10.1002/hep.29844（中科院胃肠肝病学小类1区，TOP期刊，IF: 17.425）